Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.41 |
| ▸ | MAOB | P27338 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.38 |
| ▸ | TSHR | P16473 | 2/20 | 0.37 |
| ▸ | TP53 | P04637 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | AOX1 | Q06278 | 1/20 | 0.36 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.35 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.35 |
| ▸ | MAOA | P21397 | 1/20 | 0.35 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.35 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.35 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.35 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.35 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.35 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phenylacetaldehyde SCHEMBL1412189 | 0.96 | LMNA (0.41) | LMNATAAR1MEN1KMT2AL3MBTL1 | |
| Phenylacetaldehyde SCHEMBL10892064 | 0.93 | LMNA (0.39) | LMNATAAR1MEN1KMT2AL3MBTL1 | |
| Phenylacetaldehyde SCHEMBL17267409 | 0.91 | TSHR (0.38) | LMNATAAR1MEN1KMT2AL3MBTL1 | |
| Phenylacetaldehyde SCHEMBL112416 | 0.89 | TSHR (0.40) | LMNATAAR1MEN1KMT2AL3MBTL1 | |
| Dihydrocinnamaldehyde SCHEMBL598211 | 0.84 | SMN1; SMN2 (0.41) | LMNATAAR1MEN1KMT2AL3MBTL1 | |
| Phenylacetaldehyde SCHEMBL872936 | 0.84 | TRPA1 (0.37) | LMNATAAR1MEN1KMT2AL3MBTL1 | |
| SCHEMBL8417662 | 0.84 | LMNA (0.43) | LMNATAAR1MEN1KMT2AL3MBTL1 | |
| SCHEMBL7949742 | 0.82 | TSHR (0.42) | LMNATAAR1MEN1KMT2AL3MBTL1 | |
| SCHEMBL4865476 | 0.82 | SMN1; SMN2 (0.43) | LMNATAAR1MEN1KMT2ASMN1; SMN2 | |
| Phenylacetaldehyde SCHEMBL217860 | 0.81 | TAAR1 (0.43) | TAAR1MEN1KMT2AL3MBTL1MAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 725 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2844065-B1 | LURE COMPOSITION | ATTRATEC GMBH (DE) | 2021-01-06 | — | — | EP | claimed |
| WO-2011147455-A1 | FLAVORING SUBSTANCE-INCLUDED COMPOUNDS | SYMRISE AG (DE) | 2011-12-01 | — | — | WO | claimed |
| US-20080233056-A1 | ORGANOLEPTIC COMPOUNDS WITH ENHANCED PROPERTIES | ZYMES, LLC (US) | 2008-09-25 | — | — | US | claimed |
| WO-2008116021-A1 | ORGANOLEPTIC COMPOUNDS WITH ENHANCED PROPERTIES | ZYMES, LLC (US) | 2008-09-25 | — | — | WO | claimed |
| EP-1311525-A2 | COMPOSITION AND METHOD FOR INHIBITING PLATELET AGGREGATION | Inspire Pharmaceuticals, Inc. (US) | 2003-05-21 | — | — | EP | claimed |
| US-20030036489-A1 | Consumable composition comprising perfumed particles and article containing the same | THE PROCTER & GAMBLE COMPANY | 2003-02-20 | — | — | US | claimed |
| WO-2002090479-A1 | PERFUMED PARTICLES AND ARTICLES CONTAINING THE SAME | THE PROCTER & GAMBLE COMPANY (US) | 2002-11-14 | — | — | WO | claimed |
| WO-2002090481-A1 | COMPOSITIONS AND ARTICLES FOR EFFECTIVE DEPOSITION OF PERFUME | THE PROCTER & GAMBLE COMPANY (US) | 2002-11-14 | — | — | WO | claimed |
| US-20020052337-A1 | Composition and method for inhibiting platelet aggregation | NORTH CAROLINA, UNIVERSITY OF | 2002-05-02 | — | — | US | claimed |
| WO-2002016381-A2 | COMPOSITION AND METHOD FOR INHIBITING PLATELET AGGREGATION | INSPIRE PHARMACEUTICALS, INC. (US) | 2002-02-28 | — | — | WO | claimed |
| EP-0676388-B1 | Process for the preparation of phenylacetic acid derivatives and intermediate products | BAYER AG (DE) | 1999-07-14 | — | — | EP | claimed |
| US-5756858-A | Process for the preparation of substituted phenylacetic acid derivatives and novel intermediates | BAYER AKTIENGESELLSCHAFT (DE) | 1998-05-26 | — | — | US | claimed |
| US-12630783-B2 | Muguet type fragrance compounds | SYMRISE AG (DE) | 2026-05-19 | — | — | US | disclosed |
| US-12630781-B2 | Fragrance or flavour mixture | SYMRISE AG (DE) | 2026-05-19 | — | — | US | disclosed |
| EP-4192614-B1 | PROCESS FOR THE PREPARATION OF MICROCAPSULES | SYMRISE AG (DE) | 2026-05-06 | — | — | EP | disclosed |
| US-12583833-B2 | Enrichment of a diastereomer in Magnolan | SYMRISE AG (DE) | 2026-03-24 | — | — | US | disclosed |
| US-4459224-A | Perfume compositions as well as perfumed articles and materials containing alkyl substituted benzyl cyanides as a fragrance | NAARDEN INTERNATIONAL N.V. (NL) | 1984-07-10 | — | — | US | disclosed |
| EP-0040894-B1 | PERFUME COMPOSITIONS AND PERFUMED ARTICLES CONTAINING ESTERS OF SUBSTITUTED BICYCLO (2.2.1)HEPTANE- AND HEPTENE-CARBOXYLIC ACIDS AS PERFUME BASE | NAARDEN INTERNATIONAL N.V. (NL) | 1984-01-25 | — | — | EP | disclosed |
| US-4421689-A | Derivatives of 1,5-dimethylbicyclo [3,2,1] octane, the preparation of these compounds and their use as perfume compound | SHELL ITERNATIONAL RESEARCH MAATSCHAPPIJ B.V., THE NETHERLANDS A COMPANY OF THE NETHERLANDS (NL) | 1983-12-20 | — | — | US | disclosed |
| US-4218348-A | PERFUMES | SHELL OIL COMPANY (US) | 1980-08-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12583833-B2 | Enrichment of a diastereomer in Magnolan | TRPA1, ENO1, ADH1A | LMNA 1005/4885TAAR1 593/4885MEN1 28/4885 |
| US-12630783-B2 | Muguet type fragrance compounds | MGAT1, RFT1, CPT1A | LMNA 938/4885TAAR1 1204/4885MEN1 1286/4885 |
| US-12630781-B2 | Fragrance or flavour mixture | NOTUM, FFAR2, FFAR1 | LMNA 1289/4885TAAR1 249/4885MEN1 4045/4885 |
| US-20080233056-A1 | ORGANOLEPTIC COMPOUNDS WITH ENHANCED PROPERTIES | SQLE, COQ8B, COQ8A | LMNA 476/4885TAAR1 2325/4885MEN1 951/4885 |
| US-20020052337-A1 | Composition and method for inhibiting platelet aggregation | P2RY11, P2RY12, P2RY13 | LMNA 3019/4885TAAR1 1020/4885MEN1 2541/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.